Soudabi Neduvanchery
About Soudabi Neduvanchery
Data last updated:
Soudabi Neduvanchery is a Cfo at Biocon Pharma Limited (since 2024), Director at Bestdoc Technology Private Limited (since 2016) and Director at Medisuite Life Science Private Limited (since 2022). The companies operate in Pharma, Internet and Chemicals. The 3 current companies with reported revenue have a combined latest revenue of ₹985 Cr; the largest is Biocon Pharma Limited at ₹982 Cr (FY 2025). Earlier, Soudabi Neduvanchery was an Alternate Director at Daya General Hospital Limited (2018–2020).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Biocon Pharma Limited U24232KA2014PLC077036 | Cfo | 08 Aug 2024 | 2014 | ₹982 Cr (FY 2025) | Active |
 Bestdoc Technology Private Limited U74999KL2016PTC046000 | Director | 14 Jun 2016 | 2016 | ₹2.00 Cr (FY 2022) | Active |
 Medisuite Life Science Private Limited U24290KL2022PTC077267 | Director | 05 Aug 2022 | 2022 | ₹96.1 Lakh (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Daya General Hospital Limited U85110KL1977PLC002877 | Alternate Director | 02 Jun 2018 | 1977 | ₹189 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Soudabi Neduvanchery
| Name | DIN | Company | Designation |
|---|---|---|---|
| Karaikal Narayanaswamy Murali Krishnan | 09605601 | Biocon Pharma Limited | Director |
| Kiran Mazumdar Shaw | 00347229 | Biocon Pharma Limited | Director |
| Mayank Verma | Biocon Pharma Limited | Company Secretary | |
| Siddharth Mittal | 03230757 | Biocon Pharma Limited | Whole-Time Director |
| Afsal Salu | 02909496 | Bestdoc Technology Private Limited | Managing Director |
| Fayaz Bin Abdu | 05118047 | Bestdoc Technology Private Limited | Director |
| Havahumma Abdulaziz | 02202070 | Medisuite Life Science Private Limited | Director |
| Suhana Meduvil Nalakath | 09697861 | Medisuite Life Science Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Soudabi Neduvanchery
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Soudabi Neduvanchery
Soudabi Neduvanchery currently holds 3 directorships: Biocon Pharma Limited (Cfo, since 08 Aug 2024, revenue ₹982 Cr (FY 2025)); Bestdoc Technology Private Limited (Director, since 14 Jun 2016, revenue ₹2.00 Cr (FY 2022)); Medisuite Life Science Private Limited (Director, since 05 Aug 2022, revenue ₹96.1 Lakh (FY 2024)).
Soudabi Neduvanchery was first appointed on 14 Jun 2016 as Director at Bestdoc Technology Private Limited. The most recent appointment on record is 08 Aug 2024 at Biocon Pharma Limited.
The 3 current companies of Soudabi Neduvanchery that report revenue have a combined latest revenue of ₹985 Cr: Biocon Pharma Limited ₹982 Cr (FY 2025); Bestdoc Technology Private Limited ₹2.00 Cr (FY 2022); Medisuite Life Science Private Limited ₹96.1 Lakh (FY 2024).
Soudabi Neduvanchery held 1 earlier board appointment: Daya General Hospital Limited (Alternate Director, 02 Jun 2018 to 18 Sep 2020).
The current boards of Soudabi Neduvanchery's companies include Karaikal Narayanaswamy Murali Krishnan (Biocon Pharma Limited), Kiran Mazumdar Shaw (Biocon Pharma Limited), Mayank Verma (Biocon Pharma Limited), Siddharth Mittal (Biocon Pharma Limited), Afsal Salu (Bestdoc Technology Private Limited), Fayaz Bin Abdu (Bestdoc Technology Private Limited), among others.